Vaccination With Tumor mRNA in Metastatic Melanoma - Fixed Combination Versus Individual Selection of Targeted Antigens

NCT00204516 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Malignant Melanoma

Interventions

BIOLOGICAL: mRNA coding for melanoma associated antigens
DRUG: GM-CSF

Sponsor

University Hospital Tuebingen

Collaborators

[object Object]